Cargando…
Point-of-care COVID-19 diagnostics powered by lateral flow assay
Since its first discovery in December 2019, the global coronavirus disease 2019 (COVID-19) pandemic caused by the novel coronavirus (SARS-CoV-2) has been posing a serious threat to human life and health. Diagnostic testing is critical for the control and management of the COVID-19 pandemic. In parti...
Autores principales: | Zhou, Yaofeng, Wu, Yuhao, Ding, Lu, Huang, Xiaolin, Xiong, Yonghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487324/ https://www.ncbi.nlm.nih.gov/pubmed/34629572 http://dx.doi.org/10.1016/j.trac.2021.116452 |
Ejemplares similares
-
Controlled copper in situ growth-amplified lateral flow sensors for sensitive, reliable, and field-deployable infectious disease diagnostics
por: Zhou, Yaofeng, et al.
Publicado: (2021) -
Tailoring noble metal nanoparticle designs to enable sensitive lateral flow immunoassay
por: Chen, Xirui, et al.
Publicado: (2022) -
Development of a rapid and sensitive quantum dot nanobead-based double-antigen sandwich lateral flow immunoassay and its clinical performance for the detection of SARS-CoV-2 total antibodies
por: Zhou, Yaofeng, et al.
Publicado: (2021) -
High Diagnostic Accuracy of a Novel Lateral Flow Assay for the Point-of-Care Detection of SARS-CoV-2
por: Giberti, Irene, et al.
Publicado: (2022) -
Sandwich mode lateral flow assay for point-of-care detecting SARS-CoV-2
por: Pei, Fubin, et al.
Publicado: (2023)